The association between handgrip strength and functional outcomes in long COVID-19

The association between dynapenia with long coronavirus disease 2019 (COVID-19).

The FDA Accepts MDMA for PTSD Therapy’s New Drug Application | Psychedelic Invest

The U.S. Food and Drug Administration (FDA) has recently approved a groundbreaking New Drug Application (NDA) submitted by Lykos Therapeutics for MDMA-assisted therapy in the

February 12, 2024

Merck evolves Keytruda ad campaign, building on patient insights and highlighting 16 approvals

Cancer patients don’t want to be defined by their disease. Merck’s latest campaign for its immuno-oncology blockbuster Keytruda homes in on that insight by highlighting

July 25, 2023

Risk Adjusted Net Present Value: What is the current valuation of Pfizer’s Ibuzatrelvir

The revenue for Ibuzatrelvir is expected to reach an annual total of $21 mn by 2036 in the US based off GlobalData’s Expiry Model. The

December 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.